Alexandria Real Estate Equities
ARE
#2386
Rank
ยฃ5.91 B
Marketcap
ยฃ33.96
Share price
0.85%
Change (1 day)
-18.57%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

EPS for Alexandria Real Estate Equities (ARE)

EPS in 2023 (TTM): ยฃ1.12

According to Alexandria Real Estate Equities 's latest financial reports the company's current EPS (TTM) is -ยฃ6.34. In 2022 the company made an earnings per share (EPS) of ยฃ2.36 a decrease over its 2021 EPS that were of ยฃ2.85.

EPS history for Alexandria Real Estate Equities from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)ยฃ1.12-52.48%
2022ยฃ2.36-17.41%
2021ยฃ2.85-35.32%
2020ยฃ4.4189.03%
2019ยฃ2.34-12.68%
2018ยฃ2.67124.68%
2017ยฃ1.19-179%
2016-ยฃ1.51-221.95%
2015ยฃ1.2462.38%
2014ยฃ0.76-36.87%
2013ยฃ1.2146.79%
2012ยฃ0.82-36.63%
2011ยฃ1.30-20.74%
2010ยฃ1.63-21.66%
2009ยฃ2.09-3.48%
2008ยฃ2.168.3%
2007ยฃ2.0016.23%
2006ยฃ1.720.88%
2005ยฃ1.70-9.27%
2004ยฃ1.88-23.36%
2003ยฃ2.4581.56%
2002ยฃ1.357.19%
2001ยฃ1.26-7.22%
2000ยฃ1.3621.62%
1999ยฃ1.11-8.07%
1998ยฃ1.21-217.81%
1997-ยฃ1.03

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
ยฃ0.53-108.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ23.27-466.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ13.09-306.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-ยฃ2.34-63.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
ยฃ4.44-169.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ3.40-153.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ14.92-335.27%๐Ÿ‡บ๐Ÿ‡ธ USA